HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells
{{output}}
Colorectal cancer (CRC) displays noticeable resistance to chemotherapeutic drugs or innovative tumor cell apoptosis-inducing agents such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Thus, sensitizers are needed to enhance the effects of ... ...
